바이오모아 (BioMoa) — ADC · Antibody

9268프로그램 35FDA 승인

4오늘 방문

572누적 방문

8122갱신 대기 S–CData Tier S/A/B차세대 1068HER2 breast 5456Antibody 2744CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

ADCBiologicstaleFondazione Italiana Linfomi - E…Phase 2

R-DHAP (R-DHAP)

Diffuse Large B Cell Lymphoma Refractory; Diffuse Large B-cell Lymphoma Recurrent · DLBCL

#DLBCL#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 51.4%임상시험 30상태 DISCONTINUED

AntibodystaleRegeneronPhase 2

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept IVT)

Neovascular (Wet) Age-Related Macular Degeneration · Diabetic Macular Edema

#DiabeticMacularEdema#Antibody#Phase2#항체#면역항체+3

효능 ORR 11.4%임상시험 30상태 RECRUITING

ADCBiologicstaleThe N.1 Institute for Health (N…Phase 2

Organoid-guided treatment (Organoid-guided treatment)

HER2-negative Breast Cancer; Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 30상태 RECRUITING

ADCBiologicstaleJiangsu HengRui Medicine Co., L…Phase 2

pyrotinib plus capecitabine (pyrotinib plus capecitabine)

Metastatic Breast Cancer in the Brain · Metastatic Breast Cancer in the Brain

#MetastaticBreastCancerintheBrain#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 30상태 RECRUITING

AntibodystaleJazz PharmaceuticalsPhase 3

Zanidatamab (Zanidatamab)

HER2-positive Breast Cancer; Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+4

효능 ORR 34%임상시험 30상태 RECRUITING

AntibodystaleUCB PharmaPhase 3

CDP870 (Certolizumab Pegol, Certolizumab Pegol (CDP870))

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#항체#면역항체+2

효능 ORR 5%임상시험 30상태 ACTIVE

ADCBiologicstaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab, trastuzumab-emtansine)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 69.3%임상시험 30상태 ACTIVE

AntibodystaleRochePhase 3

trastuzumab (Herceptin, Docetaxel combined + Trastuzumab +Pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2

효능 ORR 91.8%임상시험 30상태 RECRUITING

ADCBiologicstaleCalithera Biosciences, IncPhase 2

Sapanisertib (Sapanisertib)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 18.4%임상시험 30상태 RECRUITING

ADCBiologicstaleDeivis de Oliveira guimaraesPhase 2

Biolosion (Probiotics Compound, Probiotics Compound (Biolosion))

Advanced Urothelial Carcinoma; Probiotics · Advanced Urothelial Carcinoma

#AdvancedUrothelialCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 30상태 RECRUITING

CGTBiologicstaleTakedaPhase 1

anti-CD19 CAR-NK (anti-CD19 CAR-NK)

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

효능 ORR 0%임상시험 30상태 RECRUITING

ADCBiologicstaleAstraZenecaPhase 2

Vistusertib (Vistusertib)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 9.5%임상시험 30상태 RECRUITING

ADCBiologicAstraZenecaderuxtecan and rilvegostomi…Phase 2

Rilvegostomig (AZD8205 and AZD2936, AZD8205 and AZD2936 (Rilvegostomig))

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4

임상시험 30상태 RECRUITING

AntibodystaleJunshi BiosciencesPhase 2

humanized anti-PD-1 monoclonal antibody toripalimab (humanized anti-PD-1 monoclonal antibody toripalimab)

Advanced Melanoma; Metastatic Melanoma · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4

임상시험 30상태 ACTIVE

ADCBiologicstaleAstraZenecaPhase 2

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 64.3%임상시험 30상태 RECRUITING

ADCBiologicstaleAstraZenecaApproved

Dexamethasone mouthwash (Dexamethasone mouthwash)

Stomatitis · Stomatitis

#Stomatitis#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1

임상시험 30상태 RECRUITING

ADCBiologicstaleJanssen Research & Development,…Phase 2

Erdafitinib (Erdafitinib)

Muscle Invasive Bladder Urothelial Carcinoma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 46.9%임상시험 30상태 RECRUITING

AntibodystaleRochePreclinical

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2

효능 ORR 91.8%임상시험 30상태 ACTIVE

ADCBiologicstalePuma Biotechnology, Inc.Phase 2

HKI-272 (HKI-272)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 74.8%임상시험 30상태 ACTIVE

ADCBiologicstaleVerastem, Inc.Phase 2

Defactinib (Defactinib)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 3.2%임상시험 30상태 RECRUITING

AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2

효능 ORR 50%임상시험 30상태 ACTIVE

ADCBiologicstaleSeagen Inc.Phase 2

Adriamycin, vinblastine, and dacarbazine (Adriamycin, vinblastine, and dacarbazine)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 96%임상시험 30상태 ACTIVE

ADCBiologicstaleRochePhase 2

ado-trastuzumab emtansine (Kadcyla, T-DM1, T-DM1 and Pertuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 69.3%임상시험 30상태 RECRUITING

CGTBiologicAlex's Lemonade Stand FoundationPhase 1

GD2 CAR T cells (GD2 CAR T cells)

Neuroblastoma · GD2

#GD2#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 30상태 RECRUITING

AntibodystaleMarcela V. Maus, M.D.,Ph.D.Phase 2

Emapalumab (Emapalumab)

Large B-cell Lymphoma; Relapsed Non-Hodgkin Lymphoma · FRα

#FR#Antibody#Phase2#항체#면역항체+4

효능 ORR 60%임상시험 29상태 RECRUITING

28 / 167 페이지

← 이전 다음 →

전체 9,268개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 4 / 572

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

R-DHAP (R-DHAP)

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept IVT)

Organoid-guided treatment (Organoid-guided treatment)

pyrotinib plus capecitabine (pyrotinib plus capecitabine)

Zanidatamab (Zanidatamab)

CDP870 (Certolizumab Pegol, Certolizumab Pegol (CDP870))

trastuzumab (Herceptin, Pertuzumab, trastuzumab-emtansine)

trastuzumab (Herceptin, Docetaxel combined + Trastuzumab +Pertuzumab)

Sapanisertib (Sapanisertib)

Biolosion (Probiotics Compound, Probiotics Compound (Biolosion))

anti-CD19 CAR-NK (anti-CD19 CAR-NK)

Vistusertib (Vistusertib)

Rilvegostomig (AZD8205 and AZD2936, AZD8205 and AZD2936 (Rilvegostomig))

humanized anti-PD-1 monoclonal antibody toripalimab (humanized anti-PD-1 monoclonal antibody toripalimab)

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Dexamethasone mouthwash (Dexamethasone mouthwash)

Erdafitinib (Erdafitinib)

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

HKI-272 (HKI-272)

Defactinib (Defactinib)

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Adriamycin, vinblastine, and dacarbazine (Adriamycin, vinblastine, and dacarbazine)

ado-trastuzumab emtansine (Kadcyla, T-DM1, T-DM1 and Pertuzumab)

GD2 CAR T cells (GD2 CAR T cells)

Emapalumab (Emapalumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

R-DHAP (R-DHAP)

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept IVT)

Organoid-guided treatment (Organoid-guided treatment)

pyrotinib plus capecitabine (pyrotinib plus capecitabine)

Zanidatamab (Zanidatamab)

CDP870 (Certolizumab Pegol, Certolizumab Pegol (CDP870))

trastuzumab (Herceptin, Pertuzumab, trastuzumab-emtansine)

trastuzumab (Herceptin, Docetaxel combined + Trastuzumab +Pertuzumab)

Sapanisertib (Sapanisertib)

Biolosion (Probiotics Compound, Probiotics Compound (Biolosion))

anti-CD19 CAR-NK (anti-CD19 CAR-NK)

Vistusertib (Vistusertib)

Rilvegostomig (AZD8205 and AZD2936, AZD8205 and AZD2936 (Rilvegostomig))

humanized anti-PD-1 monoclonal antibody toripalimab (humanized anti-PD-1 monoclonal antibody toripalimab)

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Dexamethasone mouthwash (Dexamethasone mouthwash)

Erdafitinib (Erdafitinib)

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

HKI-272 (HKI-272)

Defactinib (Defactinib)

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Adriamycin, vinblastine, and dacarbazine (Adriamycin, vinblastine, and dacarbazine)

ado-trastuzumab emtansine (Kadcyla, T-DM1, T-DM1 and Pertuzumab)

GD2 CAR T cells (GD2 CAR T cells)

Emapalumab (Emapalumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

R-DHAP (R-DHAP)

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept IVT)

Organoid-guided treatment (Organoid-guided treatment)

pyrotinib plus capecitabine (pyrotinib plus capecitabine)

Zanidatamab (Zanidatamab)

CDP870 (Certolizumab Pegol, Certolizumab Pegol (CDP870))

trastuzumab (Herceptin, Pertuzumab, trastuzumab-emtansine)

trastuzumab (Herceptin, Docetaxel combined + Trastuzumab +Pertuzumab)

Sapanisertib (Sapanisertib)

Biolosion (Probiotics Compound, Probiotics Compound (Biolosion))

anti-CD19 CAR-NK (anti-CD19 CAR-NK)

Vistusertib (Vistusertib)

Rilvegostomig (AZD8205 and AZD2936, AZD8205 and AZD2936 (Rilvegostomig))

humanized anti-PD-1 monoclonal antibody toripalimab (humanized anti-PD-1 monoclonal antibody toripalimab)

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Dexamethasone mouthwash (Dexamethasone mouthwash)